Kübra Uçar

Kübra Uçar

Auto-generated profile, based on publicly available information

Kübra Uçar

Department of Nutrition and Dietetics, Faculty of Health Sciences Osmaniye Korkut Ata University Osmaniye Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
MUMuhammed Kursad Ucar
Muhammed Kursad Ucar
ZUZeliha Uçar
Zeliha Uçar
KUKübra Uçar
Kübra Uçar
MAMehmet Akman
Mehmet Akman
MBMehmet Recep Bozkurt
Mehmet Recep Bozkurt

12 April 2024 in Medicine
Verified
Journal Article
Open access
NENur Bengü Msc Erdem
Nur Bengü Msc Erdem
EAEvrim Kahramanoğlu Aksoy
Evrim Kahramanoğlu Aksoy
DDDerya Dikmen
Derya Dikmen
KBKübra MSc Uçar Baş
Kübra MSc Uçar Baş
AAASLIHAN AĞAÇDİKEN
ASLIHAN AĞAÇDİKEN
ZGZeynep Goktas
Zeynep Goktas
Nonalcoholic fatty liver disease (NAFLD) is considered one of the most important causes of chronic liver disorders in the world. Dietary pattern is a modifiable risk factor that represents the main target for the prevention and treatment of NAFLD. The aim of this cross-sectional study was to assess the impact of low-fat diet on anthropometric measurements, biochemical, and inflammatory parameters in individuals with obesity/overweight and NAFLD. A total of 108 individuals (n = 59 males and n = 49 females) aged between 19 and 65 years participated in the 12-week weight loss program. Dietary treatment plans including low-fat diets were randomly prescribed for each individual. Anthropometric measurements were collected by a trained dietitian at baseline and 12-week follow-up. Blood samples were collected for each individual at baseline and 3rd month for biochemical measurements and enzyme-linked immunosorbent assay analysis for tumor necrosis factor-α (TNF-α), interleukin (IL)-6, fibroblast growth factor-21 (FGF-21), chemerin, and irisin levels in plasma. At the end of the study, body weight, body mass index, body fat % body fat mass (kg) reduced significantly in females and males (P < .05). Moreover, reductions in waist, hip, and neck circumferences were significant in both groups. Changes in alanine aminotransferase and aspartate aminotransferase levels were significant in 3rd month. After 3 months, reductions in TNF-α, IL-6, and FGF-21 levels were significant in individuals with obesity/overweight and NAFLD. While no significant change in chemerin and irisin levels was found. These results show that low-fat diet over a 12-week period led to improvements in both anthropometric measurements and biochemical parameters in individuals with obesity/overweight and NAFLD.

8 July 2022 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
MUMuhammed Kursad Ucar
Muhammed Kursad Ucar
KUKübra Uçar
Kübra Uçar
ZUZeliha Uçar
Zeliha Uçar
MBMehmet Recep Bozkurt
Mehmet Recep Bozkurt

19 September 2024 in Journal of Liposome Research
Verified
Journal Article
Closed access
KBKübra Uçar Baş
Kübra Uçar Baş
AAASLIHAN AĞAÇDİKEN
ASLIHAN AĞAÇDİKEN
EDElif Didem Örs Demet
Elif Didem Örs Demet
DADilem Tuğal Aslan
Dilem Tuğal Aslan
TRTuba Reçber
Tuba Reçber
ZGZeynep Goktas
Zeynep Goktas
Naringenin may play a role in browning by increasing thermogenic gene expression. In this study, we encapsulated naringenin using a liposomal formulation and examined the effects of both free and liposomal naringenin on white adipose tissue browning in C57BL6/J mice. In the first phase of the study, naringenin was encapsulated by the liposome method, which is biocompatible and biodegradable. The physical and chemical properties of liposomal naringenin were tested. In the second phase, a total of 48 six-week-old mice were divided into two main groups: prevention and recovery. Each main group was divided into four subgroups: nano-naringenin, void, free-naringenin, and control. The prevention group received a high-fat diet for 10 weeks along with weekly intravenous injections of 20 µM naringenin. On the other hand, the recovery group was first subjected to a high-fat diet for 10 weeks, followed by an additional 10 weeks of the same diet, along with weekly intravenous injections of 20 µM naringenin. Body weight was measured once per week, and brown adipose tissue, inguinal white adipose tissue, and serum samples were collected from each mouse. The mean particle size, polydispersity index and zeta potential values of liposomal naringenin were ∼207 nm, 0.35, and -27 mV, respectively. The encapsulation and loading efficiencies of liposomal naringenin were 94.6 and 19.2%, respectively. Liposomal naringenin exhibited sustained-release behavior, while free naringenin showed a burst-release profile. Liposomal naringenin showed the best physical stability in light and at 4 °C, while free naringenin was more chemically stable in light and at 4 and 22 °C. Free and liposomal naringenin did not significantly reduce weight gain. In the prevention group, liposomal naringenin increased PRDM16 gene expression in inguinal white adipose tissue 4.29 times more than free naringenin (p = 0.010). However, neither formulation significantly altered the expression levels of other browning or adipogenesis markers in the tissues. The results suggest that free naringenin can be efficiently encapsulated in biocompatible and biodegradable nanoparticles. Further research is needed to better understand the physiological effects of liposomal naringenin.

2 June 2025 in European Journal of Lipid Science and Technology
Verified
Journal Article
Closed access
EDElif Didem Örs Demet
Elif Didem Örs Demet
KBKübra Uçar Baş
Kübra Uçar Baş
AAASLIHAN AĞAÇDİKEN
ASLIHAN AĞAÇDİKEN
DADilem Tuğal Aslan
Dilem Tuğal Aslan
TRTuba Reçber
Tuba Reçber
ZGZeynep Goktas
Zeynep Goktas

24 September 2025 in Medicina
Verified
Journal Article
Open access
PDF file
AAASLIHAN AĞAÇDİKEN
ASLIHAN AĞAÇDİKEN
KBKübra Uçar Baş
Kübra Uçar Baş
EDElif Didem Örs Demet
Elif Didem Örs Demet
DADilem Tuğal Aslan
Dilem Tuğal Aslan
TRTuba Reçber
Tuba Reçber
ZGZeynep Goktas
Zeynep Goktas
Background and Objectives: Berberine is a promising phytochemical for obesity prevention due to its effects on adipogenesis and adipose tissue browning. Despite the benefits shown in cell studies, the clinical use of berberine is limited because of its low stability and bioavailability. Materials and Methods: Our study aimed to investigate the effects of intravenous liposomal and free berberine on body weight and adipose tissue browning in C57BL/6J mice. The mice were divided into two main groups for obesity prevention and treatment: the prevention group received treatment with a high-fat diet for 10 weeks; the recovery group received treatment after 10 weeks on a high-fat diet. Treatments included liposomal berberine (10 mcM), free berberine (10 mcM), and void nano-encapsule, and PBS was used as a control. Results: Berberine did not affect body weight in the prevention group. In the treatment group, nano-berberine reduced weight gain, while free berberine caused weight loss (p < 0.05). PRDM16 and CIDEA expressions in white and brown adipose tissues were higher in the berberine-treated groups (p < 0.05). No changes were observed in UCP1, PGC1α, C/EBPβ, and FABP4 expressions. The protein concentrations of UCP1, PGC1α, and PPARγ did not change. Conclusions: The effects of liposomal berberine on gene expression and protein concentrations were not different from the free form, but the nano form had higher stability.